5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 9.80▲ | 9.82▲ | 9.86▲ | 9.92▼ | 9.77▼ |
MA10 | 9.82▲ | 9.93▲ | 9.98▲ | 9.95▼ | 10.09▼ |
MA20 | 9.95▲ | 9.86▲ | 9.88▲ | 9.89▼ | 11.20▼ |
MA50 | 10.77▼ | 11.63▼ | 11.82▼ | 10.54▼ | N/A |
MA100 | 12.33▼ | 12.36▼ | 12.25▼ | 11.38▼ | N/A |
MA200 | 11.91▼ | 12.49▼ | 12.67▼ | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.075▲ | 0.137▲ | 0.145▲ | 0.049▲ | N/A |
RSI | 48.592▼ | 45.215▼ | 44.834▼ | 41.362▼ | 33.750▼ |
STOCH | 21.398 | 25.543 | 31.367 | 57.854 | 16.065▼ |
WILL %R | -40.678 | -57.672 | -57.672 | -87.203▼ | -88.725▼ |
CCI | 79.513 | 50.433 | 51.054 | -178.798▼ | -58.482 |
Tuesday, August 12, 2025 01:57 PM
PM Eastern Time, today. LOS ANGELES, CALIFORNIA / ACCESS Newswire / August 12, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform ...
|
Monday, July 28, 2025 11:40 AM
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. eXoZymes ( (EXOZ)) has issued an ...
|
Tuesday, July 01, 2025 09:08 AM
Nasdaq handily beat the New York Stock Exchange in stock market listings during the first half of 2025, buoyed by blockbuster initial public offerings of big names like CoreWeave and Chime and a ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 9.851 | 9.851 | 9.70 | 9.70 | 500 |
14/08/25 | 9.99 | 9.99 | 9.99 | 9.99 | 0 |
13/08/25 | 10.00 | 10.06 | 9.99 | 9.99 | 2,400 |
12/08/25 | 9.88 | 10.033 | 9.88 | 10.033 | 500 |
11/08/25 | 9.862 | 9.862 | 9.862 | 9.862 | 272 |
08/08/25 | 9.748 | 10.024 | 9.679 | 9.84 | 1,200 |
07/08/25 | 10.01 | 10.01 | 10.01 | 10.01 | 0 |
06/08/25 | 9.6612 | 10.01 | 9.6612 | 10.01 | 740 |
05/08/25 | 9.63 | 10.085 | 9.63 | 10.085 | 500 |
04/08/25 | 9.84 | 9.94 | 9.84 | 9.94 | 1,400 |
|
|
||||
|
|
||||
|
|